DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: CITIUS ONCOLOGY, INC.
Filed: February 24, 2025
Period of Report: February 24, 2025
Accession Number: 0001213900-25-016636

View Document ↗ View on SEC.gov ↗